Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147

Cancer Science

Volumn 102, Issue 7, 2011, Pages 1287-1292

  Hou, Qian ^a   Tang, Xu ^b   Liu, Hanqiang ^c   Tang, Junqi ^d   Yang, Ying ^d   Jing, Xiaohong ^d   Xiao, Qian ^a   Wang, Wen ^a   Gou, Xingchun ^a,d   Wang, Zongren ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Sichuan College of Traditional Chinese Medicine   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE; CD147 ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL DEATH; CELL STRAIN HEPG2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIGENS, CD147; APOPTOSIS; AUTOPHAGY; BERBERINE; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIVER NEOPLASMS;

EID: 79959262084     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01933.x     Document Type: Article

References (42)

1. Yi ZB, Yan Y, Liang YZ et al. Evaluation of the antimicrobial mode of berberine by LC/ESI-MS combined with principal component analysis. J Pharm Biomed Anal 2007; 44: 301-4.
2. Liu JC, Chan P, Chen YJ et al. The antihypertensive effect of the berberine derivative 6-protoberberine in spontaneously hypertensive rats. Pharmacology 1999; 59: 283-9.
3. Kuo CL, Chi CW, Liu TY. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 2004; 203: 127-37.
4. Zhang W, Xu YC, Guo FJ et al. Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. Chin Med J (Engl) 2008; 121: 2124-8.
5. Kong W, Wei J, Abidi P et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004; 10: 1344-51.
6. Sun Y, Xun K, Wang Y et al. A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 2009; 20: 757-69.
7. Tang J, Feng Y, Tsao S et al. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 2009; 126: 5-17.
8. Padma S, Martinie JB, Iannitti DA. Liver tumor ablation: percutaneous and open approaches. J Surg Oncol 2009; 100: 619-34.
9. Roberts LR, Gores GJ. Emerging drugs for hepatocellular carcinoma. Expert Opin Emerg Drugs 2006; 11: 469-87.
10. Wysocki PJ. Targeted therapy of hepatocellular cancer. Expert Opin Investig Drugs 2010; 19: 265-74.
11. Lin CC, Yang JS, Chen JT et al. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Anticancer Res 2007; 27: 3371-8.
12. Mantena SK, Sharma SD, Katiyar SK. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 2006; 5: 296-308.
13. Mantena SK, Sharma SD, Katiyar SK. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 2006; 27: 2018-27.
14. Hur JM, Hyun MS, Lim SY et al. The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells. J Cell Biochem 2009; 107: 955-64.
15. Wang XN, Han X, Xu LN et al. Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomedicine 2008; 15: 1062-8.
16. Wang N, Feng Y, Zhu M et al. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. J Cell Biochem 2010; 111: 1426-36.
17. Wang N, Feng Y, Lau EP et al. F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration. Integr Cancer Ther 2010; 9: 354-64.
18. Dai JY, Dou KF, Wang CH et al. The interaction of HAb18G/CD147 with integrin alpha6beta1 and its implications for the invasion potential of human hepatoma cells. BMC Cancer 2009; 9: 337.
19. + pathways. Cell Mol Life Sci 2008; 65: 2933-42.
20. Xu J, Xu HY, Zhang Q et al. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma. Mol Cancer Res 2007; 5: 605-14.
21. Kuang YH, Chen X, Su J et al. RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion. Cancer Lett 2009; 276: 189-95.
22. Yang JM, O'Neill P, Jin W et al. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim. J Biol Chem 2006; 281: 9719-27.
23. Tang Y, Nakada MT, Kesavan P et al. Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res 2005; 65: 3193-9.
24. Chen Y, Zhang H, Gou X et al. Upregulation of HAb18G/CD147 in activated human umbilical vein endothelial cells enhances the angiogenesis. Cancer Lett 2009; 278: 113-21.
25. Gou X, Ru Q, Zhang H et al. HAb18G/CD147 inhibits starvation-induced autophagy in human hepatoma cell SMMC7721 with an involvement of Beclin 1 down-regulation. Cancer Sci 2009; 100: 837-43.
26. Drachman JG, Miyakawa Y, Luthi JN et al. Studies with chimeric Mpl/JAK2 receptors indicate that both JAK2 and the membrane-proximal domain of Mpl are required for cellular proliferation. J Biol Chem 2002; 277: 23544-53.
27. Mizushima N, Noda T, Yoshimori T et al. A protein conjugation system essential for autophagy. Nature 1998; 395: 395-8.
28. Pattingre S, Tassa A, Qu X et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-39.
29. Garcia GE, Nicole A, Bhaskaran S et al. Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract. Neoplasia 2006; 8: 523-33.
30. Kumar AP, Bhaskaran S, Ganapathy M et al. Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract. Clin Cancer Res 2007; 13: 2784-94.
31. Takeuchi H, Kondo Y, Fujiwara K et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitors. Cancer Res 2005; 65: 3336-46.
32. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6: 463-77.
33. Peng PL, Kuo WH, Tseng HC et al. Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int J Radiat Oncol Biol Phys 2008; 70: 529-42.
34. Letasiova S, Jantova S, Cipak L et al. Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. Cancer Lett 2006; 239: 254-62.
35. Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res 2001; 61: 2276-81.
36. Jia L, Wei W, Cao J et al. Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells. Ann Hematol 2009; 88: 753-60.
37. Wang B, Xu Y-F, He B-S et al. RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro. J Exp Clin Cancer Res 2010; 29: 61.
38. Baba M, Inoue M, Itoh K et al. Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism. Biochem Biophys Res Commun 2008; 374: 111-6.
39. Tang Y, Nakada M, Rafferty P et al. Regulation of vascular endothelial growth factor expression by EMMPRIN via the PI3K-Akt signaling pathway. Mol Cancer Res 2006; 4: 371-7.
40. Li J, Peng L, Wu L et al. Depletion of CD147 sensitizes human malignant melanoma cells to hydrogen peroxide-induced oxidative stress. J Dermatol Sci 2010; 58: 204-10.
41. Qiu F, Zhu Z, Kang N et al. Isolation and identification of urinary metabolites of berberine in rats and humans. Drug Metab Dispos 2008; 36: 2159-65.
42. James MA, Fu H, Liu Y et al. Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis. Mol Carcinog 2010; 50: 1-7.